INTEGRA pipettes accelerate COVID-19 testing for pediatric hospital group

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes and EVOLVE manual pipettes are playing pivotal roles in COVID-19 testing at Children’s Minnesota, an award-winning, non-profit acute pediatric healthcare group in the ‘twin cities’ of Saint Paul and Minneapolis. These innovative tools have helped the group’s molecular laboratory to process more samples, more effectively in this unpredictable sociomedical period.

The rise of the pandemic has forced the 16-strong laboratory team to restructure its workflows and expand its in-house capacity to enable high-priority COVID-19 testing. To help meet this challenge, the team invested in a number of six and 12 channel VOYAGER adjustable tip spacing pipettes – as well as single channel EVOLVE manual pipettes – using the increased availability of equipment and multichannel pipetting capabilities to rapidly expand their workload.

These ergonomic pipettes have also helped to alleviate some of the wrist and hand pain associated with repetitive sample transfers, as some laboratory staff were starting to develop repetitive strain injury.

The INTEGRA pipettes are well made and really user friendly. The VOYAGER’s adjustable spacing makes it very simple to pipette between racks of different standard formats, allowing us to seamlessly move from sample extraction to amplification to detection. This reduces the total number of transfer steps by moving multiple samples rapidly in parallel, substantially shortening processing times. It has also decreased the number of errors compared to using a single channel pipette, and we now almost exclusively use the VOYAGER and EVOLVE pipettes for COVID-19 testing.”

Julie Laramie, Laboratory Technical Specialist, Children’s Minnesota

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2022, June 29). INTEGRA pipettes accelerate COVID-19 testing for pediatric hospital group. AZoLifeSciences. Retrieved on December 06, 2024 from https://www.azolifesciences.com/news/20220426/INTEGRA-pipettes-accelerate-COVID-19-testing-for-pediatric-hospital-group.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA pipettes accelerate COVID-19 testing for pediatric hospital group". AZoLifeSciences. 06 December 2024. <https://www.azolifesciences.com/news/20220426/INTEGRA-pipettes-accelerate-COVID-19-testing-for-pediatric-hospital-group.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA pipettes accelerate COVID-19 testing for pediatric hospital group". AZoLifeSciences. https://www.azolifesciences.com/news/20220426/INTEGRA-pipettes-accelerate-COVID-19-testing-for-pediatric-hospital-group.aspx. (accessed December 06, 2024).

  • Harvard

    INTEGRA Biosciences. 2022. INTEGRA pipettes accelerate COVID-19 testing for pediatric hospital group. AZoLifeSciences, viewed 06 December 2024, https://www.azolifesciences.com/news/20220426/INTEGRA-pipettes-accelerate-COVID-19-testing-for-pediatric-hospital-group.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Streamlined Laboratory Integration With INTEGRA’s Electronic and Automated Liquid Handling Solutions